These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31846303)

  • 1. Modulating ALS-Related Amyloidogenic TDP-43
    Laos V; Bishop D; Lang CA; Marsh NM; Cantrell KL; Buratto SK; Singh AK; Bowers MT
    Biochemistry; 2020 Feb; 59(4):499-508. PubMed ID: 31846303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
    Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computationally Designed Molecules Modulate ALS-Related Amyloidogenic TDP-43
    Liu X; Duan S; Jin Y; Walker E; Tsao M; Jang JH; Chen Z; Singh AK; Cantrell KL; Ingolfsson HI; Buratto SK; Bowers MT
    ACS Chem Neurosci; 2023 Dec; 14(24):4395-4408. PubMed ID: 38050862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing TDP-43
    Laos V; Do TD; Bishop D; Jin Y; Marsh NM; Quon B; Fetters M; Cantrell KL; Buratto SK; Bowers MT
    ACS Chem Neurosci; 2019 Sep; 10(9):4112-4123. PubMed ID: 31430111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD.
    Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP
    Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting and Remodeling Toxic Amyloid-Beta Oligomer Formation Using a Computationally Designed Drug Molecule That Targets Alzheimer's Disease.
    Downey MA; Giammona MJ; Lang CA; Buratto SK; Singh A; Bowers MT
    J Am Soc Mass Spectrom; 2019 Jan; 30(1):85-93. PubMed ID: 29713966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
    Fang YS; Tsai KJ; Chang YJ; Kao P; Woods R; Kuo PH; Wu CC; Liao JY; Chou SC; Lin V; Jin LW; Yuan HS; Cheng IH; Tu PH; Chen YR
    Nat Commun; 2014 Sep; 5():4824. PubMed ID: 25215604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic Cross Talk between Key Peptide Fragments That Couple Alzheimer's Disease with Amyotrophic Lateral Sclerosis.
    Laos V; Bishop D; Ganguly P; Schonfeld G; Trapp E; Cantrell KL; Buratto SK; Shea JE; Bowers MT
    J Am Chem Soc; 2021 Mar; 143(9):3494-3502. PubMed ID: 33621087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The era of cryptic exons: implications for ALS-FTD.
    Mehta PR; Brown AL; Ward ME; Fratta P
    Mol Neurodegener; 2023 Mar; 18(1):16. PubMed ID: 36922834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
    Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
    Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
    Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
    Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.